Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00273143 · ClinicalTrials.gov registry record
A Trial to Study How the Body Fights Off Cytomegalovirus (CMV) in Hematopoietic Transplant Recipients.
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 50
- Enrollment target
NCT00273143: Completed study, sponsored by Mayo Clinic.
NCT00273143 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00273143 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
This study is being done to determine how the body fights off a common virus known as Cytomegalovirus (CMV). CMV is a virus that commonly infects humans and causes disease in patients with compromised immune function such as those who receive organ and tissue transplant. By knowing how the human body responds to the infection, researchers will be able to develop better methods on how to prevent this infection.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2005-05 |
| Est. Completion | 2007-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00273143
The ClinicalTrials.gov registry entry for NCT00273143 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00273143 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00273143 about?
NCT00273143 is a clinical study titled "A Trial to Study How the Body Fights Off Cytomegalovirus (CMV) in Hematopoietic Transplant Recipients.". This study is being done to determine how the body fights off a common virus known as Cytomegalovirus (CMV). CMV is a virus that commonly infects humans and causes disease in patients with compromised immune function such as those who receive organ and tissue transplant. By knowing how the human bod...
What is the current status of trial NCT00273143?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2005-05. Estimated completion is 2007-04.
Who is sponsoring clinical trial NCT00273143?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.